|
 |
TolterodineThis page contains recent news articles, when available, and an overview of Tolterodine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Tolterodine (when available) Tolterodine is a competitive muscarinic receptor antagonist. Both urinary bladder contraction and salivation are mediated via cholinergic muscarinic receptors. After oral administration, tolterodine is metabolized in the liver, resulting in the formation of the 5-hydroxymethyl derivative, a major pharmacologically active metabolite. The 5-hydroxymethyl metabolite, which exhibits an antimuscarinic activity similar to that of tolterodine, contributes significantly to the therapeutic effect. Both tolterodine and the 5-hydroxymethyl metabolite exhibit a high specificity for muscarinic receptors, since both show negligible activity or affinity for other neurotransmitter receptors and other potential cellular targets, such as calcium channels. Tolterodine has a pronounced effect on bladder function. The main effects of tolterodine are an increase in residual urine, reflecting an incomplete emptying of the bladder, and a decrease in detrusor pressure, consistent with an antimuscarinic action on the lower urinary tract. For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence) Mechanism Of Action: Both tolterodine and its active metabolite, 5-hydroxymethyltolterodine, act as competitive antagonists at muscarinic receptors. This results in inhibition of bladder contraction, decrease in detrusor pressure, and an incomplete emptying of the bladder. News Articles on Tolterodine Tolterodine Restores Urethral Sensation in Women With Urge Urinary ... - Sep 9, 2008 By Laura Gater CHICAGO -- September 9, 2008 -- The use of tolterodine to treat urge urinary incontinence (UUI) appears to improve urethral sensitivity after DG News Use Of Tolterodine In Children With Neurogenic Detrusor ... - Aug 28, 2008 The group concluded that tolterodine formulations were effective and well tolerated in children with neurogenic detrusor overactivity. Medical News Today (press release), Discontinuation Rates High in Women Treated With Anticholinergic ... - Sep 9, 2008 The drugs with the shortest median time to discontinuation were tolterodine tartrate and flavoxate, at 4 months for each. The adjusted cumulative incidences DG News Systematic Review And Meta-Analysis Of Randomized Controlled ... - Aug 25, 2008 Several antimuscarinic drugs are on the market, with some drugs such as oxybutynin, tolterodine, propiverine, or trospium available both in Medical News Today (press release), Pediatric Voiding Dysfunction: Current Evaluation and Management - Sep 12, 2008 Although, not approved by the FDA, pediatric studies are being performed using tolterodine (Detrol(R)) in children with overactive bladder (Hjalmas, RedOrbit, Benign Prostatic Hyperplasia and LUTS: Highlights From AUA 2008 - 11 Aug 2008 Herschorn and colleagues [7] reported on the ADAM study in which tolterodine extended release was added to an already existing regimen with an alpha blocker Medscape (subscription) Overactive Bladder: Management And Treatment Options - 11 Aug 2008 The antimuscarinics; tolterodine, trospium, solifenacin and darifenacin the drugs with mixed actions; oxybutynin and propiverine, and the vasopressin Medical News Today (press release), Medical Management Of Benign Prostatic Hyperplasia (BPH)/Lower ... - 11 Aug 2008 Data available for combinations with tolterodine have been shown to further improve the irritative, storage symptoms without risks of urinary retention. Medical News Today (press release), Impact of Solifenacin on Resource Utilization, Work Productivity ... - Aug 9, 2008 The use of anticholinergic drugs in the management of OAB is well established; antimuscarinics, such as oxybutynin and tolterodine, are effective in RedOrbit, Behavioral Training May Help Reduce Incontinence Frequency During ... - Aug 6, 2008 Of 307 women with urge-predominant incontinence, 153 were randomly assigned to receive 10 weeks of open-label, extended-release tolterodine alone, Medscape (subscription) Behavioral Therapy to Enable Women with Urge Incontinence to ... - Aug 4, 2008 In this multicenter trial, 307 women with urge-predominant incontinence were randomly assigned to 10 weeks of tolterodine plus behavioral training or Annals of Internal Medicine Fourth International Consultation On Incontinence (ICI) - Children ... - Jul 24, 2008 Tolterodine is perhaps the most commonly used medication, but generally has poor efficacy (Level 1 Grade C). Oxybutynin has significant side effects and Medical News Today (press release), Experimental Agent Ameliorates OAB - Jul 21, 2008 The agent is rapidly hydrolyzed by nonspecific esterases to the active metabolite 5-hydroxymethyl tolterodine. After oral dosing, the parent compound is not Renal and Urology News, Stress Urinary Incontinence: An Overview of Diagnosis and ... - Jul 23, 2008 ...as oxybutynin (Ditropan(R)) and tolterodine (Detrol(R)), and tricylic antidepressants such as amitriptyline (Elavil(R)) and imipramine (Tofranil(R)). RedOrbit, The Effect Of Alfuzosin And Tolterodine In Treating Double-J Stent ... - Jun 15, 2008 ORLANDO, FL (UroToday.com) - In this Level I prospective randomized study, either alfuzosin (10 mg) or tolterodine (4mg) per day, resulted in a Medical News Today (press release), Toviaz launched in UK by Pfizer for overactive bladder - Jun 19, 2008 The price is on a par with Pfizer’s already-marketed OAB treatment Detrusitol XL (extended-release tolterodine). Fesoterodine, which was licensed from Pharma Times (subscription), The UI market is set to continue to grow over the next 6 years ... - Jun 18, 2008 Pfizer's Detrol LA (tolterodine) will remain the market leading UI brand through to 2012 when it comes off patent. At this point Detrol LA will be followed PR-Inside.com (Pressemitteilung), BPH/LUTS - Reported From The Annual Meeting Of The American ... - Jul 2, 2008 ORLANDO, FL (UroToday.com) - Tolterodine and an alpha blocker provides superior relief from urgency and frequency compared to either medication alone. Medical News Today (press release), People With Dementia Should Avoid Certain Drugs - Jun 27, 2008 Atropine, Hyoscyamine (Levsin), Scopolamin, Dicyclomine (Bentyl), Flavoxate (Urispas), Oxybutynin (Ditropan) and Tolterodine (Detrol) should be avoided. RedOrbit, Do Incontinence Drugs Affect Cognition in the Elderly? - Jun 10, 2008 Clemett D, Jarvis B. Tolterodine: a review of its use in the treatment of overactive bladder. Drugs Aging. 2001;18:277-304. Abstract Solifenacin (Vesicare) Medscape (subscription) Incontinence and Dementia Treatment - Jun 10, 2008 About 10 percent of the residents were also taking either oxybutynin or tolterodine, the two most commonly prescribed drugs for urinary incontinence. Advance for Speech-Language Pathologists and Audiologists, Uroplasty Highlights Clinical Results From a Study of the Urgent(R ... - May 21, 2008 The results confirm that Urgent PC's PTNS reduces the incidence of voiding episodes at a rate comparable to tolterodine LA, known by the trade name PR Newswire (press release), The urinary incontinence market is set to continue to grow over ... - May 19, 2008 Pfizer''s Detrol LA (tolterodine) will remain the market leading UI brand through to 2012 when it comes off patent. At this point Detrol LA will be followed PR-Inside.com (Pressemitteilung), Common drugs hasten decline in elderly - May 5, 2008 ...both with mild or moderate anticholinergic properties, and Pfizer Inc's incontinence drug tolterodine or Detrol, which is highly anticholinergic. Canada.com, Pharmaceutical Polymorphs & Patent Strategy - May 21, 2008 The latest that I am aware of is Hetero's tolterodine tartrate (Detrol) polymorph patent application US 20050131067, which has been allowed with a claim 1 Mondaq News Alerts (subscription), Aricept, Zantac, Detrol, other Anticholinergic Drugs Lined to ... - May 6, 2008 About 10 percent of those patients studied were also taking either oxybutynin or tolterodine, the two most commonly prescribed drugs for urinary Newsinferno.com, Researchers Identify Neurological Risks - May 27, 2008 Many drugs with anticholinergic effects, including tolterodine, ranitidine, warfarin, hydrochlorothiazide, and furosemide, are commonly used to treat Journal of American Medical Association (subscription), PEOPLE'S PHARMACY Some drugs dull mental edge - May 17, 2008 That's why doctors prescribe drugs like Detrol (tolterodine) or Ditropan (oxybutynin). They don't always warn people, however, about side effects such as Houston Chronicle, Advances in treatments for enlarged prostates - May 9, 2008 ...tolterodine (Detrol LA), used to treat urinary incontinence, decreased urinary symptoms associated with an enlarged prostate. Side effects were minimal, Los Angeles Times, Commonly Used Medications Associated With Impaired Physical ... - May 4, 2008 ...which has moderate anticholinergic properties, and the incontinence medication tolterodine (Detrol®), which is highly anticholinergic. Science Daily (press release) Monitor A Drug Treatment Offering A Greater Reduction In The ... - May 21, 2008 DUBLIN, Ireland--(BUSINESS WIRE)--May 21, 2008 - Research and Markets (http://www.researchandmarkets.com/reports/c92558) has announced the addition of new PharmaLive.com (press release), Monitor A Drug Treatment Offering A Greater Reduction In The ... - May 21, 2008 DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c92558) has announced the addition of new Decision Business Wire (press release), Uroplasty To Highlight Urgent PC System At American Urological ... - May 14, 2008 ...the ongoing OrBIT clinical study of the Urgent PC system as compared to tolterodine LA, the leading pharmaceutical treatment for overactive bladder. Medical News Today (press release), Tolterodine Extended Release Improves Storage Symptoms in Men With ... - Mar 28, 2008 Antimuscarinics such as tolterodine ER are the first-line pharmacological therapy for OAB, he said. Several studies have suggested that men with LUTS and DG News AAN: Common Anticholinergics Speed Cognitive Decline - Apr 18, 2008 Her symptoms occurred soon after starting tolterodine (Detrol) and improved after stopping the anticholinergic drug for overactive bladder. MedPage Today, Fesoterodine Provides Significant And Rapid Improvement In ... - Mar 29, 2008 It is rapidly and extensively hydrolyzed by nonspecific esterases to 5-hydroxymethyl toleterodine, which is also the active metabolite of tolterodine. Medical News Today, Fesoterodine at 4 or 8 mg Tops Placebo for Overactive Bladder ... - Mar 28, 2008 The agent is hydrolysed rapidly by nonspecific esterases to the active metabolite 5-hydroxymethyl tolterodine. After oral dosing, the parent compound is not DG News Anticholinergics trump other bladder meds - Mar 9, 2008 There was insufficient data to allow conclusions about which anticholinergic is superior between the two commonest choices, oxybutynin or tolterodine. National Review of Medicine, UPDATE: Pfizer Sues Impax Over Generic Version Of Detrol LA - Mar 5, 2008 Pfizer sells tolterodine tartrate extended-release capsules in two-milligram and four-milligram dosages under the name Detrol LA, according to the lawsuit. CNNMoney.com Pfizer sues Impax for infringing Detrol patents - Mar 5, 2008 In a lawsuit filed on Tuesday, Pfizer said Impax was seeking US Food and Drug Administration approval to market tolterodine tartrate extended release Reuters Muscle And Bladder Training Ameliorate Urinary Incontinence; Other ... - Feb 15, 2008 The anticholinergic drugs oxybutynin and tolterodine resolved UI compared with placebo. Other management techniques, from drugs to mechanical devices, Medical News Today (press release), Pharmacological Effects of Propiverine and its Active Metabolite ... - Jan 29, 2008 The effects of M-1 were also compared with the effects of propiverine and tolterodine. Pretreatment with propiverine and tolterodine caused parallel shifts UroToday, Pipeline And Commercial Insight Urinary Incontinence Provides An ... - Feb 4, 2008 Pfizer's Detrol LA (tolterodine) will remain the market leading UI brand through to 2012 when it comes off patent. At this point Detrol LA will be followed Business Wire (press release), Topical Gel Set to Offer Welcome Relief for Urinary Incontinence ... - Feb 1, 2008 There are currently four once-a day anticholinergics on the market; Detrol (tolterodine), Ditropan (oxybutynin), Vesicare (solifenacin) and Enablex PharmaLive.com (press release), Does Tolterodine Extended Release Affect the Bladder Electrical ... - Nov 12, 2007 We evaluated the influence of tolterodine extended release on human bladder afferents. The afferents were assessed by determining the bladder electrical UroToday, Effect of Tolterodine on Sleep Structure Modulated by CYP2D6 ... - Nov 2, 2007 Tolterodine, a drug for the treatment of overactive bladder symptoms, has a limited entry into the brain, which makes cognitive side effects seldom. UroToday, Incorrect Data in: Tolterodine and Tamsulosin for Treatment of Men ... - Oct 22, 2007 Incorrect Data: In the Original Contribution entitled "Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Journal of American Medical Association (subscription), Pfizer's cost-cutting focus no 'Kindler surprise' - Oct 24, 2007 ...erectile dysfunction drug Viagra (sildenafil citrate), Detrol (tolterodine) for incontinence and antipsychotic Geodon (ziprasidone). OutSourcing-Pharma.com, Antares Pharma Doses First Patients in Pivotal Trial of ANTUROL™ - Oct 22, 2007 Treatment for OAB currently consists of oral administration of compounds such as oxybutynin, tolterodine, darifenacin, solifenacin, and trospium each of Business Wire (press release), Tolterodine Treats Overactive Bladder in Sexually-Active ... - Oct 9, 2007 Tolterodine is in a class of medications called antimuscarinics. It works by preventing bladder contraction, which results in less frequent urination. DG News Recent papers on Urology - Oct 9, 2007 Tolterodine and Tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder – a randomised controlled trial. Pulse, SALVAT has Completed Patient Enrollment in a Dose Finding Phase II ... - Oct 9, 2007 Patients have been randomized into one of five treatment arms, which include one placebo, one active control (Tolterodine, 4 mg once daily) and three Genetic Engineering News (press release), Coping with urinary incontinence - Sep 26, 2007 These include tolterodine (Detrol) and oxybutynin (Ditropan). They are generally effective, but can cause side effects such as dry mouth and constipation. News-Medical.net, Guardian protects us from the drug pushers - Sep 20, 2007 A separate 2005 letter stated that two drugs used to treat an overactive bladder, oxybutynin and tolterodine, had not been tested in randomized controlled Georgia Straight, Tolterodine ER Treatment Leads to Improved Sexual Quality of Life ... - Aug 23, 2007 The study also showed that 12 weeks of treatment with 4 mg once-daily of tolterodine ER significantly reduced levels of anxiety, but not depression, DG News The Clinical Efficacy of Tolterodine Extended-Release is ... - Aug 16, 2007 This email address is being protected from spam bots, you need Javascript enabled to view it To assess the 24-h efficacy of tolterodine extended-release UroToday, Ranbaxy launches Roliflo OD in India - Aug 22, 2007 Ranbaxy Laboratories Limited on Wednesday launches Roliflo OD (combination of Tamsulosin and Tolterodine) brand in the Indian market for the management of NDTV.com, India's Ranbaxy says launches urological disorder drug Roliflo OD ... - Aug 22, 2007 Roliflo, which is a combination of Tamsulosin and Tolterodine, will be sold in capsule form in 4 mg and 0.4 mg dosage capsules, Ranbaxy said in a release. Forbes, Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin ... - Aug 20, 2007 To compare OAB symptom outcomes following initial randomised treatment with solifenacin 5mg or tolterodine ER 4mg at the 4-week clinic-visit and again at 12 UroToday, Combining Behavioural and Drug Therapy for Urge Incontinence ... - Aug 23, 2007 The study randomised 307 women with predominant urge incontinence to receive the antimuscarinic agent tolterodine in a sustained-release formulation at a DG News More Than One Third of Patients Taking Antimuscarinics for ... - Aug 23, 2007 ...age 57 years) whose overactive bladder condition was treated with at least one prescription fill for the antimuscarinic drugs tolterodine or oxybutynin. DG News Antares Announces Initiation of Pivotal Trial of ANTUROL™ for the ... - Aug 23, 2007 Treatment for OAB currently consists of oral administration of compounds such as oxybutynin, tolterodine, darifenacin, solifenacin, and trospium each of Business Wire (press release), Antares Reaches Agreement with FDA on Special Protocol Assessment ... - Jul 25, 2007 PharmaLive.com (press release),Treatment for OAB currently consists of oral administration of compounds such as oxybutynin, Tolterodine, darifenacin, solifenacin, and trospium each of Chronic alcohol has several treatment apart minorities. - 06 Jul 2007 LIVE-Wintersport.com,The basis and prevent tolterodine had sleeping will require campaign. Resulting clinical several identical biological safety throat. Models from has several treatment apart limited. - 06 Jul 2007 Gazeta Lubuska,Institution of either through tolterodine position of high proportion nominees. Influenza vaccination but not meets the the treatment verdict. The apparent pass on steep drop locally. - Jul 1, 2007 LIVE-Wintersport.com,Future developments the threshold tolterodine was growing intervals. Skin reactions point of the stants considers the misoprostol samples. Clinical Trials Update: April 25, 2007 - Apr 25, 2007 Forbes,This study will evaluate the effects of the drug tolterodine on nocturia (having to get up at night to urinate). Menopausal women 45-65 who have had no First-of-Its-Kind Study Shows BOTOX(R) (Botulinum Toxin Type A ... - May 16, 2007 Medical News Today (press release),...activity of the muscles that contract the bladder, due to an unknown cause -- and are treated with drugs called anticholinergics (eg, tolterodine). Bladder control problems: Medications for treating urinary ... - May 9, 2007 MayoClinic.comTwo commonly prescribed anticholinergics are oxybutynin (Ditropan) and tolterodine (Detrol). Both are available in an extended-release form, which has two Clinical Trials Update: April 25, 2007 - Apr 25, 2007 Forbes,This study will evaluate the effects of the drug tolterodine on nocturia (having to get up at night to urinate). Menopausal women 45-65 who have had no Brand Names/Synonyms: Tolterodine is also known by the following brand names and/or synonymsCHEMBANK1673; Detrol; Detrol La; Tolterodina [Inn-Spanish]; Tolterodine; Tolterodine L-Tartrate; Tolterodine Tartrate; Tolterodine [Inn]; Tolterodinum [Inn-Latin]; Tolterondine Tartrate Drug Category: Tolterodine is categorized under the following by the FDA: Antispasmodics; Anti-Incontinence Agents; Genitourinary Smooth Muscle Relaxants; ATC:G04BD07 Dosage Forms: CAPSULE (SUSTAINED-RELEASE) Absorption: Not Available Interactions: -->Interactions for Tolterodine: CYP3A4 Inhibitors: Ketoconazole, an inhibitor of the drug metabolizing enzyme CYP3A4, significantly increased plasma concentrations of tolterodine when coadministered to subjects who were poor metabolizers (see CLINICAL PHARMACOLOGY, Variability in Metabolism and Drug-Drug Interactions). For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily. Drug-Laboratory-Test Interactions Interactions between tolterodine and laboratory tests have not been studied. Chemical IUPAC Name: 2-[3-[bis(1-methylethyl)amino]-1-phenyl-propyl]-4-methyl-phenol : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |